Innoviva News - INVA

Company Name	Stock Ticker Symbol	Market	Type
Innoviva Inc	INVA	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	-0.17	-1.12%	14.99	09:41:39

Open Price	Low Price	High Price	Close Price	Prev Close
15.08	14.98	15.09		15.16

more quote information »

Recent News

Date	Time	Source	Heading
4/25/2024	8:52	IHNW	FeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
4/24/2024	07:00	BW	Innoviva Specialty Therapeutics’ Positive Phase 3 Oral..
3/07/2024	19:04	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/07/2024	19:02	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/07/2024	19:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
3/07/2024	18:57	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/29/2024	17:01	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/29/2024	16:15	EDGAR2	Form 8-K - Current report
2/29/2024	16:05	BW	Innoviva Reports Fourth Quarter and Full Year 2023 Financial..
2/22/2024	21:31	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/22/2024	21:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2/14/2024	07:23	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/22/2024	21:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
1/10/2024	20:26	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
11/17/2023	16:30	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
11/06/2023	08:30	EDGAR2	Form 8-K - Current report
11/01/2023	16:30	EDGAR2	Form 8-K - Current report
11/01/2023	16:15	BW	Innoviva Reports Third Quarter 2023 Financial Results and..
11/01/2023	16:05	BW	Positive Results Announced in Largest Pivotal Phase 3 Trial..
9/19/2023	08:30	BW	Innoviva to Participate in the Cantor Global Healthcare..
9/18/2023	08:00	BW	XACDURO®, The First and Only Antibiotic Developed to Target..
8/31/2023	20:12	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/31/2023	13:58	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/25/2023	17:24	EDGAR2	Form 8-K - Current report
8/25/2023	16:52	BW	Innoviva Appoints Stephen Basso as Chief Financial Officer
8/07/2023	16:42	EDGAR2	Form 8-K - Current report
8/02/2023	21:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/02/2023	16:15	EDGAR2	Form 8-K - Current report
8/02/2023	16:05	BW	Innoviva Reports Second Quarter 2023 Financial Results and..
7/11/2023	08:16	EDGAR2	Form 8-K - Current report
6/06/2023	16:05	BW	Innoviva to Participate in the Goldman Sachs Annual Global..
5/23/2023	19:10	DJN	FDA Approves Innoviva's Bacterial Pneumonia Treatment
5/23/2023	18:42	BW	Innoviva Specialty Therapeutics Announces FDA Approval for..
5/11/2023	18:45	BW	Results from Pivotal Phase 3 ATTACK Trial of Investigational..
5/09/2023	16:32	BW	Innoviva Reports First Quarter 2023 Financial Results and..
4/28/2023	17:30	BW	Innoviva Announces Retirement of Board Chairman